Health

Pfizer, Sanofi-Avensis End Studies on Diet Drugs

Pfizer Inc.and Sanofi-Aventis on Wednesday separately announced their decision to cancel further...

» read full story

November 07th, 2008 - 16:00

Pfizer Halts Phase III Trial On Obesity Drug Over US Rejection Fears

Pfizer Inc., the world’s largest drugmaker, on Wednesday said it abandoned an obesity drug known...

» read full story

November 06th, 2008 - 14:30

Sales of Sanofi’s Anti-Obesity Drug Acomplia Suspended In Europe

Warnings about Sanofi-Aventis’ anti-obesity rimonabant (Acomplia) had always accompanied the drug,...

» read full story

October 24th, 2008 - 15:30

Merck’s Discontinuation On Taranabant Development

Merck & Co. has decided to bring to an end the development the experimental obesity drug...

» read full story

October 05th, 2008 - 16:16

Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant

Merck & Co. on Thursday announced its decision to cancel further investigation into its...

» read full story

October 03rd, 2008 - 16:30

Farewell To Development Of Obesity Drug Taranabant

Merck halted the research of the experimental obesity drug taranabant because of the dangerous side...

» read full story

October 03rd, 2008 - 14:01

Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects

Merck Research Laboratories developed a new drug, called taranabant, which helped people shed...

» read full story

January 09th, 2008 - 11:35